A Leading Vertically-Integrated North American Operator
TerrAscend is a leading North American cannabis operator with vertically integrated operations in Pennsylvania, New Jersey, and California, licensed cultivation and processing operations in Maryland and licensed production in Canada. TerrAscend operates an award-winning chain of The Apothecarium dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities on both the East and West coasts.
TerrAscend’s best-in-class cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use market. The Company owns several synergistic businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc.
TerrAscend strives to set strong achievable objectives for our organization and maintain the culture, processes and communication systems which facilitate the organization’s ability to achieve these objectives. Our Core Values set the standard expectations on how we work together to accomplish our common set of goals. We hold each other accountable in living these values, leading by example every day.
Award-Winning Stores and Leading Cultivation
The Apothecarium was founded by three first cousins and two family friends in San Francisco in 2011. On the West Coast, we have three dispensaries in San Francisco, one in Berkeley, and one in Capitola, California. On the East Coast, our dispensaries are located in Lancaster, Thorndale and Plymouth Meeting, Pennsylvania, as well as Phillipsburg, and Maplewood, New Jersey.
TerrAscend also operates three additional dispensaries in Stroudsburg, Allentown and Bethlehem, Pennsylvania under the Keystone Canna Remedies brand.
Cultivation and Processing
TerrAscend is committed to producing high-quality, in-demand medical grade cannabis products at its industry leading cultivation facilities for distribution into the wholesale market as well as direct sales at its retail dispensaries.
Through the combination of high-yield cultivation techniques, industry leading cultivars, and strategic investments in the latest technology, TerrAscend produces cannabis products for both medical patients and consumers.
APRIL 21, 2021
Marijuana MSO TerrAscend buys Pennsylvania dispensaries for $63M
MJ BIZ DAILY
FEBRUARY 22, 2021
New Jersey Finally Legalizes Marijuana (But You Can’t Buy Any—Yet)
FEBRUARY 19, 2021
TerrAscend Posts Prelim Net Sales Of CA$65M, Touts ‘Robust Sequential Revenue Growth’
FEBRUARY 5, 2021
See inside N.J.’s newest marijuana cultivation facility